Iroquois Homeobox 5 Negatively Regulated by miRNA-147 Promotes the Proliferation, Metastasis, and Invasion by Oral Squamous Cell Carcinoma

Leukemia aggressiveness is driven by chromatin remodeling and expression changes of core regulators

Molecular mechanisms driving clonal aggressiveness in leukemia are not fully understood. We tracked and analyzed two mouse MLL-rearranged leukemic clones independently evolving towards higher aggressiveness. More aggressive subclones lost their growth differential ex vivo but restored it upon secondary transplantation, suggesting molecular memory of aggressiveness. Development of aggressiveness was associated with clone-specific gradual modulation of chromatin states and expression levels across the genome, with a surprising preferential trend of reversing the earlier changes between normal and leukemic progenitors. To focus on the core aggressiveness program, we identified genes with consistent changes of expression and chromatin marks that were maintained in vivo and ex vivo in both clones. Overexpressing selected core genes (Smad1 as aggressiveness driver, Irx5 and Plag1 as suppressors) affected leukemic progenitor growth in the predicted way and had convergent downstream effects on central transcription factors and repressive epigenetic modifiers, suggesting a broader regulatory network of leukemic aggressiveness.

A Novel Vaccaria Semen Carbonisatum Carbon Nanocomposites and Their Protective Effects on Alcohol-Induced Liver Injury in Mice

Objective: To discover the efficacy of Vaccariae Semen Carbonisatum nano-components (VSC-NCs) on alcoholic liver injury in mice. Methods: VSC was calcined at high temperature in a muffle furnace, and VSC-NCs were extracted and isolated. Mouse model of alcoholic liver injury was used and alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), total bile acid (TBA), oxidative stress and histopathological assessments were done. Results: Characterization and analysis showed that VSC-NCs were spherical, with a particle size distribution of 1.0 to 5.5 nm. The results of animal experiments showed that VSC-NCs could significantly reduce the content of ALT, AST, TBA and ALP in mice with alcohol-induced liver injury, and at the same time significantly increase the level of SOD and reduce the level of malondialdehyde. These results indicated that VSC-NCs could improve the scavenging of reactive oxygen species (ROS) in the body. The ability to reduce the production of lipid peroxides, so as to achieve hepatoprotective effect. Conclusion: VSC-NCs were prepared for the first time, and was confirmed that it has a significant protective effect on liver injury caused by alcohol. In addition, VSC-NCs can be used as a potential drug for the treatment of alcohol-induced liver injury.